Non-Therapeutic Protocol

BRAIN2: The Brigance Assessment Of Individual Neurodevelopment In Young Children With Sickle Cell Disease-2

Type of Protocol/Clinical Study

Associated Hematology Studies : Sickle cell disease

Description

Central nervous system complications including stroke, silent infarcts (death of tissue due to a lack of blood flow) and neurocognitive difficulties (difficulty with thinking and learning) are some of the most overwhelming consequences of sickle cell disease (SCD). As a result, young children with SCD may have academic problems. Most studies involving neurocognitive testing of children with SCD have focused on school-aged children; very few have examined preschool-age children. Because thinking and learning difficulties appear to begin before a child with SCD is 5 years old, this study will focus on 3-year olds. The participants will be given the Brigance Preschool Screen-II, one of the most often used tests to study learning development. The duration of the study will be for 3 years.


Objectives


Eligibility

Inclusion Criteria


Exclusion Criteria

Principal Investigator

Winfred Wang, MD

The above information is intended to provide only a basic description about a research protocol that may be currently active at St. Jude. The details made available here may not be the most up-to-date information on protocols used by St. Jude. To receive full details about a protocol and its status and or use at St. Jude, a physician must contact St. Jude directly.